SLC20A2 Gene Basal Ganglia Calcification Type 1 Idiopathic NGS Genetic DNA Test
Comprehensive Genetic Testing for Brain Calcification Disorders
The SLC20A2 Gene Basal Ganglia Calcification Type 1 Idiopathic NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the SLC20A2 gene, which plays a critical role in phosphate transport and calcium metabolism within the brain. When this gene malfunctions, it can lead to primary familial brain calcification (PFBC), a condition characterized by abnormal calcium deposits primarily in the basal ganglia region of the brain.
What This Test Measures and Detects
Our sophisticated NGS (Next-Generation Sequencing) technology comprehensively analyzes the entire SLC20A2 gene to identify:
- Pathogenic mutations causing basal ganglia calcification
- Single nucleotide variants affecting phosphate transport
- Insertion/deletion mutations disrupting gene function
- Copy number variations impacting gene expression
- Novel variants associated with idiopathic calcification
The test provides detailed information about specific genetic alterations that contribute to the development of brain calcification, enabling precise diagnosis and personalized treatment approaches.
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Unexplained movement disorders including parkinsonism
- Progressive cognitive decline or dementia symptoms
- Psychiatric manifestations such as depression or psychosis
- Speech difficulties and coordination problems
- Family history of basal ganglia calcification
- Unexplained neurological symptoms with brain imaging showing calcification
- Early-onset neurological conditions without clear diagnosis
Significant Benefits of Genetic Testing
Undergoing the SLC20A2 genetic test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out genetic causes of brain calcification
- Family Planning: Enables informed reproductive decisions for at-risk families
- Treatment Guidance: Helps neurologists develop targeted treatment strategies
- Prognostic Information: Provides insight into disease progression and management
- Early Intervention: Allows for proactive management of symptoms
- Genetic Counseling: Supports comprehensive family risk assessment
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation of your results:
- Positive Result: Indicates the presence of a pathogenic SLC20A2 mutation. This confirms the genetic basis of brain calcification and enables targeted management strategies.
- Negative Result: Suggests that SLC20A2 mutations are not responsible for the condition, guiding physicians to investigate alternative causes.
- Variant of Uncertain Significance: Some genetic changes may require additional family studies or research correlation.
All results are accompanied by detailed clinical interpretation and recommendations for next steps, including consultation with our genetic specialists.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| SLC20A2 Gene Basal Ganglia Calcification Type 1 Idiopathic NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Availability
We have comprehensive testing facilities across the United States, with branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures convenient access to advanced genetic testing regardless of your location.
Take Control of Your Neurological Health
Don’t let unexplained neurological symptoms remain a mystery. Our SLC20A2 genetic test provides the clarity needed for effective management of brain calcification disorders. With our advanced NGS technology and expert genetic analysis, you’ll receive comprehensive insights into your genetic profile.
Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your neurological health and making informed decisions about your care.
